|
Drug Delivery Series: The Market for Advanced Drug Delivery Technology Systems: Volume 5Published by: Kalorama Information Published: Feb. 1, 2002 - 114 Pages Order 2 or more reports in this series and save 25-40%! Call 800-298-5699Table of Contents Chapter One: Executive Summary
Market Drivers Market Size and Growth Competitive and Market Analysis Chapter Two: Introduction and Overview
Introduction Scope and Methodology Reasons for Advanced Drug Delivery Systems Phases of Drug Action Liposome Drug Delivery Polymer Drug Delivery Monoclonal Antibodies Drug Delivery Chapter Three: Trends and Developments Expansion of Biotechnology Incorporation of Technology Molecular Imprinted Polymers Pharmacoeconomics of Drug Delivery Systems Gene Therapy Drug Delivery Metallofullerenes Antisense Delivery Systems Camouflaged Nanoparticles Microfabrication Thermosetting Biodegradable Polymer Triggerable Drug Delivery VP22 Drug Delivery Prodrug Drug Delivery Single Chain Antigen-Binding Protein Technology Magnetic Targeted Carriers Heat Shock Protein Technology Other Emerging Drug Delivery Technologies Chapter Four: Market Size and Growth Chapter Five: Competitive and Market Analysis Competitive Landscape Market Analysis Chapter Six: Company Profiles Alkermes, Inc. Alza Corporation Andrx Corporation Atrix Laboratories, Inc. Biovail Corporation Centocor, Inc. Control Delivery Systems, Inc. Elan Corporation, Plc EnColl Corporation, Inc. Enzon, Inc. Gilead Sciences, Inc. Guilford Pharmaceuticals, Inc. IDEC Pharmaceuticals Corporation MacroMed, Inc. Protein Design Labs, Inc. Appendix: Company Directory List of Exhibits Table 2-1: Sequence of Drug Action Table 2-2: Marketed Monoclonal Antibodies, 2000 Table 4-1: The Worldwide Market for Advanced Drug Delivery Systems by Type, 1995-2005 Table 4-2: The Worldwide Market for Advanced Drug Delivery Systems, Market Share by Type, 1995-2005 Table 4-3: The Worldwide Market for Advanced Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005 Table 4-4: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005 Table 5-1: Worldwide Market for Advanced Drug Delivery System, Revenues and Market Share by Supplier, 2000 Figure 4-1: The Worldwide Market for Advanced Drug Delivery Systems, Revenues by Type, 1995-2005 Figure 4-2: The Worldwide Market for Advanced Drug Delivery Systems, Share by Type, 2000 Figure 4-3: The Worldwide Market for Advanced Drug Delivery Systems, Share by Type, 2005 Figure 4-4: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005 Figure 4-5: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000 Figure 4-6: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005 Figure 5-1: Worldwide Market for Advanced Drug Delivery Systems, Market Share by Leading Supplier, 2000 AbstractDrug Delivery Series: The Market for Advanced Drug Delivery Technology Systems: Volume 5Volume 5 of the Drug Delivery Series will address advanced drug delivery technologies, including such cutting edge technology as liposome drug delivery, polymer and polymeric micelles, micro-particulates, DNA binding, monoclonal antibodies, gene therapy and micro-encapsulation. Emerging technologies are continuing to bring many developmental advances to the pharmaceutical industry. |
|
|||
|
About MarketResearch.com
|
||||